ICIs can “release the brakes,” reactivating suppressed T cells and restoring their ability to kill tumor cells by blocking the binding of PD-L1 on the surface of tumor cells to PD-1 on the surface of T cells (12). The gene discussed is CD274; the disease is neoplasm.